CellWell record HH-21122
Lactobacillus fermentum (PCC®) supplementation and gastrointestinal and respiratory-tract illness symptoms: a randomised control trial in athletes
Nicholas P West; David B Pyne; Allan W Cripps; William G Hopkins; Dorte C Eskesen; Ashok Jairath; Claus T Christophersen; Michael A Conlon; Peter A Fricker
Nutrition Journal · 2011
In plain language
In 99 competitive cyclists, 11 weeks of Lactobacillus fermentum (PCC) increased fecal Lactobacillus counts and was linked to reduced severity of gastrointestinal illness and fewer respiratory symptom days in men, with unclear effects in women.
- Evidence
- Emerging
- Design
- Randomized controlled trial
Cite this record: https://thecellwell.org/studies/HH-21122
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.